APO-ESCITALOPRAM
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-ESCITALOPRAM in Canada?
Yes. APO-ESCITALOPRAM 10MG has an active shortage reported to Health Canada (last updated November 17, 2026).
Why is APO-ESCITALOPRAM not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-ESCITALOPRAM be available again?
The manufacturer's estimated resolution date is January 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ACH-ESCITALOPRAM
ACCORD HEALTHCARE INC
MYLAN-ESCITALOPRAM
MYLAN PHARMACEUTICALS ULC
NRA-ESCITALOPRAM
NORA PHARMA INC
AURO-ESCITALOPRAM
AURO PHARMA INC
CIPRALEX -10MG
LUNDBECK CANADA INC
MAR-ESCITALOPRAM
MARCAN PHARMACEUTICALS INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2027-01-15
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02295016
Strength
10MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ESCITALOPRAM
Tier
Unrated
Last Updated
2026-11-17
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
APO-ESCITALOPRAM has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554178
2MG · DIN 02554194